Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/07/2025 ,inter alia, to consider and approve Unaudited Financial Results ....
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech has informed the exchanges that its Board of Directors will meet on Saturday, July 19, 2025, to consider and approve the Unaudited Financial Results (both standalone and consolidated) for the quarter ended June 30, 2025 (Q1 FY26). The filing is a routine regulatory intimation under SEBI Listing Regulations and does not contain any actual financial numbers. The company also confirmed that the insider trading window remains closed for designated persons and their immediate relatives from July 1, 2025 until 48 hours after the results are announced.
This is a procedural notice with no direct impact on the stock price. Investors should watch the July 19 announcement for the actual Q1 FY26 numbers, which will be the first quarterly update on the company's performance for the new financial year.